Statement Of Cash Flows [Abstract]

Redcare Pharmacy N.V. - Filing #1833429

Concept As at
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
As at
2018-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
16,771,000 EUR
36,270,000 EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for income tax expense
329,000 EUR
4,000 EUR
Adjustments for decrease (increase) in inventories
24,552,000 EUR
13,339,000 EUR
Adjustments for depreciation and amortisation expense
16,064,000 EUR
14,864,000 EUR
Adjustments for unrealised foreign exchange losses (gains)
234,000 EUR
29,000 EUR
Adjustments for share-based payments
4,405,000 EUR
2,967,000 EUR
Interest received, classified as operating activities
93,000 EUR
1,333,000 EUR
Cash flows from (used in) operating activities
17,802,000 EUR
30,728,000 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
38,235,000 EUR
4,003,000 EUR
Purchase of intangible assets, classified as investing activities
15,100,000 EUR
10,739,000 EUR
Cash flows from (used in) investing activities
40,257,000 EUR
33,400,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
63,381,000 EUR
49,148,000 EUR
Payments of lease liabilities, classified as financing activities
2,362,000 EUR
2,456,000 EUR
Cash flows from (used in) financing activities
50,286,000 EUR
102,442,000 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
27,832,000 EUR
38,314,000 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
0 EUR
0 EUR
Cash and cash equivalents
90,485,000 EUR
62,653,000 EUR
24,338,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.